Michael Schmertzler

Director, Ptc Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$6.6M

Companies

Latest trade

Oct 14, 2026

Companies

Ptc Therapeutics, Inc.Director −$6.6M

Trades

PTCT Sold 2,500 shares at $59.61 · planned $0.1M Oct 14

PTCT Sold 2,500 shares at $63.39 · planned $0.2M Oct 7

PTCT Sold 10,000 shares at $67.85 · planned $0.7M Sep 17

PTCT Sold 10,000 shares at $67.12 · planned $0.7M Sep 16

PTCT Sold 10,000 shares at $67.34 · planned $0.7M Sep 10

PTCT Sold 10,000 shares at $67.84 · planned $0.7M Sep 9

PTCT Sold 12,500 shares at $71.58 · planned $0.9M Aug 27

PTCT Sold 12,500 shares at $72.94 · planned $0.9M Aug 26

PTCT Sold 12,500 shares at $71.11 · planned $0.9M Aug 20

PTCT Sold 12,500 shares at $73.32 · planned $0.9M Aug 19

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.